[Improvement of treatment of inflammatory diseases in oral cavity].
In order to determine the anti-pathogenic clinical efficacy of cycloferon liniment in the combined treatment of herpetic stomatitis and periodontitis, medical examination and treatment of these disorders have been carried out in a group of 80 patients. It is established that the use of cycloferon liniment in the combined treatment of herpetic stomatitis and periodontitis decreases the infectious load in parodontal recess, reduces the manifestations of local inflammation, normalizes the immunity indices, and decreases the level of endogenous intoxication, which ensures the acceleration of recuperation processes and lowers the frequency of recurrences.
L A
LA
Soboleva
A A
AA
Shul'diakov
O G
OG
Khlamova
M G
MG
Romantsov
D000166:Acridines / Q000494:pharmacology / Q000627:therapeutic use*; D000212:Acyclovir / Q000494:pharmacology / Q000627:therapeutic use; D000328:Adult; D002176:Candida albicans / Q000187:drug effects / Q000276:immunology; D002692:Chlamydia trachomatis / Q000187:drug effects / Q000276:immunology; D005260:Female; D006801:Humans; D007118:Immunoassay; D007070:Immunoglobulin A / Q000032:analysis / Q000276:immunology; D007249:Inflammation / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology / Q000473:pathology / Q000821:virology; D007369:Interferon Inducers / Q000494:pharmacology / Q000627:therapeutic use; D053583:Interleukin-1beta / Q000032:analysis / Q000276:immunology; D008038:Liniments / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D009055:Mouth / Q000187:drug effects* / Q000276:immunology / Q000382:microbiology / Q000473:pathology / Q000821:virology; D010518:Periodontitis / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D012008:Recurrence; D012720:Severity of Illness Index; D018139:Simplexvirus / Q000187:drug effects* / Q000276:immunology; D013283:Stomatitis, Herpetic / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology / Q000821:virology; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis / Q000276:immunology
D000166:Acridines; D007070:Immunoglobulin A; D007369:Interferon Inducers; D053583:Interleukin-1beta; D008038:Liniments; D014409:Tumor Necrosis Factor-alpha; D000212:Acyclovir; C026430:10-carboxymethyl-9-acridanone